Haemonetics Corp. (NYSE:HAE) updated its FY14 earnings guidance on Monday. The company provided earnings per share guidance of $2.30-2.40 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.32, American Banking News.com reports. The company issued revenue guidance of +5-7% YoY $937-954.5 million, compared to the consensus revenue estimate of […]
Haemonetics Corp. (HAE) Issues FY14 Earnings Guidance is a post from: Zolmax
The post Haemonetics Corp. (HAE) Issues FY14 Earnings Guidance appeared first on Zolmax.